Almost half a century ago, in the first January 1973 issue of Science , the Roger Guillemin group in the Salk Institute (La Jolla, California), published a paper that proved the presence of a bioactive peptide in ovine hypothalamic extracts, with inhibitory effect in the secretion of ...
Recent data have indicated that 68Ga-DOTA-NOC positron emission tomography/X-ray computed tomography (PET/CT) may yield improved images in a shorter acquisition protocol than 111In-DTPA-octreotide (OctreoScan®, OCT). Therefore, we performed a prospective comparison of 68Ga-DOTA-NOC and OCT ...
Scintigraphy of lung tumors is made with 2 alternative somatostatin analogs, (111)In-DTPA-octreotide or (99m)Tc-depreotide. The aim of this study was to compare the biodistribution of these 3 radiopharmaceuticals in SCLC xenografted to nude mice. METHODS: Nude mice, bearing tumors from the ...
64Cu-DOTATATE PET for neuroendocrine tumors: a prospective head-to-head comparison with 111In-DTPA-octreotide in 112 patients. J Nucl Med. 2015;56:847... Pfeifer, AndreasKnigge, UlrichBinderup, TinaMortensen, JannOturai, PeterLoft, AnnikaBerthelsen, Anne KiilLanger, Seppo W.Rasmussen, PalleEl...
Evaluation of the Therapeutic Response to In-111-DTPA Octreotide-Based Targeted Therapy.Evaluation of the Therapeutic Response to In-111-DTPA Octreotide-Based Targeted Therapy.Thirteen (13) patients with liver neuroendocrine carcinomas metastases, positive for somatostatin receptors, confirmed by scintigraphy...
111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide ther- apy of NETs. Eur J Nucl Med Mol Imaging 2012;39 Suppl 1: S113-25.J. B. Bomanji and N. D. Papathanasiou, "111In-DTPA0- octreotide (Octreoscan), 131I-MIBG and other agents for radio- ...
The pancreas showed highest median uptake of 111In-DTPA-octreotide; 4.1 Bq/voxel. The median uptake in liver tumours and subcutaneous tumours was 2.6 Bq/voxel. Conclusion Tumor microenvironment can affect tumor characteristics, as shown in this study by differences observed in the uptake of ...
PURPOSE Although somatostatin receptor PET/CT gains increasing popularity, In-111-DTPA-octreotide is still the current standard for diagnosis of neuroendocrine tumors (NET). In several studies somatostatin receptor PET/CT has shown its superiority in lesion detection and localization suggesting a reduction...
Value of Peptide Receptor Scintigraphy Using 123 I-Vasoactive Intestinal Peptide and 111 In-DTPA-D-Phe1-Octreotide in 194 Carcinoid Patients: Vienna University Experience, 1993 to 1998 来自 onAcademic 喜欢 0 阅读量: 17 作者: M Raderer,A Kurtaran...
Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours. Radiol Med. 2008;113: 1056-67.Castaldi P, Rufini V, Treglia G, Bruno I, Perotti G, Stifano G, Barbaro B, Giordano A. Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the ...